Skip to main content
Signal8
Launch Terminal

Bambusa Therapeutics, Inc. (BBTX)

Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Bambusa Therapeutics Inc. logo

Bambusa Therapeutics Inc.

NASDAQ:BBTXHealthcare
$14.99
AH$14.21-5.20%vs close
Mkt Cap$745.93M
Float3.53M
O/S49.76M
Vol
$ Vol
RVOL
Inst Own-
Earnings
Dilution
Bambusa Therapeutics Inc. logoNASDAQ:BBTX$14.99
FormDescription
424B4
Prospectus
6
S-8
SEC Filing
2
EFFECT
Notice of Effectiveness
1
S-1MEF
SEC Filing
2
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
CERT
SEC Filing
8-A12B
SEC Filing
S-1/A
Registration Statement (Amended)
6
S-1
Registration Statement
8
DRS/A
SEC Filing
DRS
SEC Filing
D
06b
D
06b
D
06b